tetano
Editor, Senior Moderator
Immunity. 2017 Oct 17;47(4):599-603. doi: 10.1016/j.immuni.2017.09.007.
[h=1]The Pathway to a Universal Influenza Vaccine.[/h] Paules CI[SUP]1[/SUP], Marston HD[SUP]1[/SUP], Eisinger RW[SUP]1[/SUP], Baltimore D[SUP]2[/SUP], Fauci AS[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.
Copyright ? 2017.
PMID: 29045889 DOI: 10.1016/j.immuni.2017.09.007
[h=1]The Pathway to a Universal Influenza Vaccine.[/h] Paules CI[SUP]1[/SUP], Marston HD[SUP]1[/SUP], Eisinger RW[SUP]1[/SUP], Baltimore D[SUP]2[/SUP], Fauci AS[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.
Copyright ? 2017.
PMID: 29045889 DOI: 10.1016/j.immuni.2017.09.007